- Home
- LITB vs ESLA Comparison
LITB vs ESLA Comparison
Compare LITB & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LITB
- ESLA
- Stock Information
- Founded
- LITB 2007
- ESLA 2021
- Country
- LITB Singapore
- ESLA United States
- Employees
- LITB N/A
- ESLA N/A
- Industry
- LITB Catalog/Specialty Distribution
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LITB Consumer Discretionary
- ESLA Health Care
- Exchange
- LITB Nasdaq
- ESLA Nasdaq
- Market Cap
- LITB 32.7M
- ESLA 35.5M
- IPO Year
- LITB N/A
- ESLA N/A
- Fundamental
- Price
- LITB $1.21
- ESLA $1.01
- Analyst Decision
- LITB
- ESLA Strong Buy
- Analyst Count
- LITB 0
- ESLA 1
- Target Price
- LITB N/A
- ESLA $16.00
- AVG Volume (30 Days)
- LITB 15.5K
- ESLA 23.1K
- Earning Date
- LITB 05-13-2025
- ESLA 05-14-2025
- Dividend Yield
- LITB N/A
- ESLA N/A
- EPS Growth
- LITB N/A
- ESLA N/A
- EPS
- LITB 0.08
- ESLA N/A
- Revenue
- LITB $231,136,000.00
- ESLA N/A
- Revenue This Year
- LITB N/A
- ESLA $101.09
- Revenue Next Year
- LITB N/A
- ESLA N/A
- P/E Ratio
- LITB $15.25
- ESLA N/A
- Revenue Growth
- LITB N/A
- ESLA N/A
- 52 Week Low
- LITB $0.91
- ESLA $0.63
- 52 Week High
- LITB $6.00
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- LITB 44.21
- ESLA 50.50
- Support Level
- LITB $1.19
- ESLA $0.97
- Resistance Level
- LITB $1.43
- ESLA $1.04
- Average True Range (ATR)
- LITB 0.10
- ESLA 0.06
- MACD
- LITB 0.01
- ESLA -0.00
- Stochastic Oscillator
- LITB 23.51
- ESLA 63.27
About LITB LightInTheBox Holding Co. Ltd.
LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.